of 5
Featured News
Some of the leading stories and synthetic biology information from SynbiCITE
12 Oct 2018
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at...
12 Oct 2018
Addressing Global Challenges
Expert insights from SynbiCITE's leadership on the role of synthetic biology in solving some of the most significant challenges currently faced by our society
UK Synthetic Biology start-up survey 2017
The UK’s first survey of the Synthetic Biology industry following a year of significant progress.
SynbiCITE’s UK Synthetic Biology start-up survey 2017 will assess the current and potential size of the Synthetic Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have. The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available this summer.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK to accelerate the commercialisation of world-class science and emerging technologies encompassed by synthetic biology into new products, tools, processes and services.
Innovation, education & collaboration
Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.
Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.
We partner with some of the world’s most forward-thinking organisations
We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.
View our network
Synthetic Biology community
Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Addressing Global Challenges
Expert insights from SynbiCITE's leadership on the role of synthetic biology in solving some of the most significant challenges currently faced by our society
Evonetix makes key appointments to support development of novel gene synthesis technology
CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthes...
2018 Meeting on UK Synthetic Genomics
On the 17th September 2018, a one-day meeting entitled "Synthesising a Human Genome: What could go right? " was held at the Wellcome Trust in London...
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at...
Buildings made from fungi? Meet London’s pop-up bio-lab innovators
If there’s one place you wouldn’t expect a new biotech research lab to be built, it’s slap bang in the middle of a busy London marketFind out more her...
Evonetix establishes scientific advisory board
CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...
Synthace launches ground-breaking new whitepaper
Comprehensive report heralds the beginning of Computer Aided Biology (CAB)LONDON October 01 2018 - Synthace Ltd., the company behind the leading cloud...
A Lloyd's Emerging Risk Report
Synthetic biology, the application of engineering principles to genetic modification is a market forecast to grow to $39bn by 2020. In recent years sc...
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution
Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...
SynbiCITE launches new five-year strategy
SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, launches a new five-year strategy underpinned by a new £5M grant from UKRI and other sources.
New competition - metasurfaces for defence and security
This themed competition is seeking proposals for innovative solutions that will pull ideas from recent breakthroughs in metasurface science into produ...